重度妊娠期高血压的母婴结局评估
本研究为单中心回顾性队列研究,纳入2018年2月至12月分娩的妊娠期高血压疾病妇女,比较重度妊娠期高血压与其他类型高血压疾病的母婴结局。主要结局为小于胎龄儿,重度妊娠期高血压与无严重特征子痫前期相比无差异,但前者其他母婴病率更高。
要点
- 重度妊娠期高血压与无严重特征子痫前期的小于胎龄儿风险无差异。
- 重度妊娠期高血压患者其他母婴病率高于无严重特征子痫前期或轻度妊娠期高血压。
- 结果支持近期指南对重度妊娠期高血压按子痫前期伴严重特征管理的推荐。
核心结论
- 重度妊娠期高血压与无严重特征子痫前期相比,小于胎龄儿发生率无差异。
- 重度妊娠期高血压患者其他母婴病率高于无严重特征子痫前期或轻度妊娠期高血压。
研究设计与样本
- 回顾性队列研究,纳入单中心三级医疗中心2018年2月至12月分娩的妊娠期高血压疾病妇女。
- 排除慢性高血压、HELLP综合征、孕前肾肝风湿血液疾病或多胎妊娠者。
- 共2076例符合纳入标准,其中重度妊娠期高血压254例(12.2%),无严重特征子痫前期379例(18.2%)。
主要发现
- 重度妊娠期高血压与无严重特征子痫前期的小于胎龄儿发生率分别为14.7%和9.8%,调整后OR 0.72(95%CI 0.44-1.21)。
- 无严重特征子痫前期患者出院时接受降压药处方的OR为0.11(95%CI 0.06-0.22),产后再入院OR为0.14(95%CI 0.04-0.50),均低于重度妊娠期高血压组。
临床怎么用
- 重度妊娠期高血压应按子痫前期伴严重特征进行管理。
- 需关注重度妊娠期高血压患者其他母婴病率,加强产后随访。
局限性
- 单中心回顾性研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertensive disorders of pregnancy are widespread and have long-standing implications for women's health. Historically, the management of "severe gestational hypertension," or the presence of severely elevated blood pressures without any other signs or symptoms of end-organ damage meeting the criteria for preeclampsia, has been unclear. The new American College of Obstetricians and Gynecologists guidelines based on expert opinion recommend that severe gestational hypertension be treated similarly to preeclampsia with severe features, but data regarding outcomes for women with this diagnosis have been limited. OBJECTIVE: This study aimed to compare the maternal and perinatal sequelae of severe gestational hypertension with that of other types of hypertensive disorders of pregnancy. STUDY DESIGN: This is a retrospective cohort study of women with hypertensive disease of pregnancy who delivered at a single tertiary care center between February and December 2018. Women with chronic hypertension; hemolysis, elevated liver enzymes, and low platelet count syndrome; preexisting kidney, liver, rheumatologic, or hematologic disorders; or multifetal pregnancies were excluded. Women were categorized as having severe gestational hypertension if they had a sustained systolic blood pressure of >160 mm Hg or a diastolic blood pressure of >110 mm Hg without other criteria for preeclampsia. The primary comparison was between women with severe gestational hypertension and women with preeclampsia without severe features. Secondary comparisons included women with severe gestational hypertension vs women with other types of hypertensive disease of pregnancy. The primary outcome for this analysis was small-for-gestational-age birth. We also evaluated other maternal and neonatal morbidities including but not limited to pulmonary embolism, stroke, eclampsia, blood transfusion, mechanical ventilation, intensive care unit admission, death, 5-minute Apgar score of ≤4, umbilical cord pH, neonatal intensive care unit admission of >2 days, respiratory distress syndrome, and neonatal death. Bivariate analyses using chi-square tests and logistic regressions adjusting for race, ethnicity, age, body mass index, parity, and insurance status were performed to compare frequencies of outcomes for each type of hypertensive disease of pregnancy with those of severe gestational hypertension. RESULTS: Of 2076 women eligible for inclusion, 12.2% (n=254) had severe gestational hypertension and 379 (18.2%) had preeclampsia without severe features. Although there was no difference in the odds of small-for-gestational-age birth between women with severe gestational hypertension and women with preeclampsia without severe features (14.7% vs 9.8%; adjusted odds ratio, 0.72; 95% confidence interval, 0.44-1.21), the latter were significantly less likely to receive a prescription for antihypertensive medication at discharge (OR 0.11, 95% CI 0.06-0.22) or to be readmitted postpartum (OR 0.14, 95% CI 0.04-0.50). CONCLUSION: There was no difference in the primary outcome, that is, rate of small-for-gestational-age birth, between women with severe gestational hypertension and women with preeclampsia without severe features. However, women with severe gestational hypertension had greater odds of other maternal and neonatal morbidities than women with preeclampsia without severe features or mild gestational hypertension. These findings support recent recommendations regarding the management of women with severe gestational hypertension.
引用
- Kumar NR, Grobman WA, Barry O, et al. Evaluating the maternal and perinatal sequelae of severe gestational hypertension. Am J Obstet Gynecol MFM. 2020. PMID: 33451611. doi:10.1016/j.ajogmf.2020.100280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。